Get software! [General Sta­tis­tics]

posted by verstc – China, 2018-06-17 14:55  – Posting: # 18910
Views: 3,629

Dear Helmut,

Thanks a lot for your reply.

It is clear to me for your explain.

I am wondering if there is a way to reduce the intra-subject CV. I think intra-subject CV is an inherent characteristic of a drug. is it right? If it not, does anyone can reduce it by any ways?

Thanks,

best,
Shawn


Edit: Full quote removed. Please delete everything from the text of the original poster which is not necessary in understanding your answer; see also this post #5[Helmut]

Complete thread:

Activity
 Admin contact
20,456 posts in 4,296 threads, 1,413 registered users;
online 10 (0 registered, 10 guests [including 9 identified bots]).
Forum time (Europe/Vienna): 19:32 CEST

No one wants to learn from mistakes, but we cannot learn enough
from successes to go beyond the state of the art.    Henry Petroski

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5